Skip to main content
TipRanks
Go Ultimate75% OFF

STONEPINE CAPITAL, L.P. Insider Profile

4 Followers

STONEPINE CAPITAL, L.P., former Ten Percent Owner at Novelion Therapeutics, holds 3.91M shares in Novelion Therapeutics (Ticker: NVLNF), holds 1.58M shares in Apollo Endosurgery (Ticker: APEN). Most recently, STONEPINE CAPITAL, L.P. Bought ― shares of Novelion Therapeutics on Dec 12, 2019 for an estimated value of $4.32K.

STONEPINE CAPITAL, L.P.'s Trading History

NVLNF
Novelion Therapeutics
Dec 12, 2019―Informative Buy4.32K$2.74M
APEN
Apollo Endosurgery
Aug 14, 2019―Uninformative Sell―$15.81M

You May Also Like

STONEPINE CAPITAL, L.P. insider profile FAQ

What is the percentage of profitable transactions made by STONEPINE CAPITAL, L.P.?
The percentage of profitable transactions made by STONEPINE CAPITAL, L.P. is 30%.
What is the average return per transaction made by STONEPINE CAPITAL, L.P.?
The average return per transaction made by STONEPINE CAPITAL, L.P. is -7.40%.
What stocks does STONEPINE CAPITAL, L.P. hold?
STONEPINE CAPITAL, L.P. holds: NVLNF, APEN stocks.
What was STONEPINE CAPITAL, L.P.’s latest transaction?
STONEPINE CAPITAL, L.P.’s latest transaction was an Informative Buy of $4.32K.
What was STONEPINE CAPITAL, L.P.'s most profitable transaction?
STONEPINE CAPITAL, L.P.’s most profitable transaction was an Informative Buy of APEN stock on August 18, 2017. The return on the trade was 79.40%.
What is STONEPINE CAPITAL, L.P.'s role in Novelion Therapeutics?
STONEPINE CAPITAL, L.P.'s role in Novelion Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.